Serabelisib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Serabelisib, covering 2020-05-21 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer [Phase 2]